Blog
RSS FeedPosted by Michael Wonder on 15 Oct 2020
EMA cancer symposium: new approaches in patient-focused cancer medicine development
15 October 2020 - On Thursday, 29 October, EMA is hosting a symposium to discuss new approaches to facilitating and ...
Posted by Michael Wonder on 05 Jul 2020
Oxford University is leading in the vaccine race
2 July 2020 - Governments are pouring money into a more urgent version of the space race. ...
Posted by Michael Wonder on 24 Jun 2020
Global regulators discuss data requirements for phase 3 trials of COVID-19 vaccines
24 June 2020 - Under the umbrella of the International Coalition of Medicines Regulatory Authorities, international regulators discussed COVID-19 vaccine ...
Posted by Michael Wonder on 27 May 2020
Prospective dialogue between developers and regulators makes for better evidence generation
27 May 2020 - EMA, in collaboration with other parties, has recently published two scientific articles outlining the importance of ...
Posted by Michael Wonder on 20 May 2020
Europe falls behind U.S. in funding coronavirus vaccine and securing access
19 May 2020 - U.S. was faster in shouldering drug companies’ costs to develop and manufacture vaccine candidates, putting the bloc ...
Posted by Michael Wonder on 18 May 2020
EU actions to support availability of medicines during COVID-19 pandemic – update #6
15 May 2020 - The EU Executive Steering Group on Shortages of Medicines Caused by Major Events held a virtual ...
Posted by Michael Wonder on 05 May 2020
World leaders donate to COVID-19 vaccine funding drive
5 May 2020 - Experts says $20 billion needed to vaccinate global population. ...
Posted by Michael Wonder on 04 May 2020
A future for regulatory science in the European Union: the European Medicines Agency’s strategy
4 May 2020 - After 3 years of co-design with stakeholders and EU regulatory partners, the European Medicines Agency’s Regulatory Science ...
Posted by Michael Wonder on 04 May 2020
COVID-19: how EMA fast-tracks development support and approval of medicines and vaccines
4 May 2020 - As researchers race to develop vaccines and therapeutics against COVID-19, EMA has published an overview of how ...
Posted by Michael Wonder on 04 May 2020
AstraZeneca to make Oxford vaccine as COVID-19 race heats up
30 April 2020 - AstraZeneca agreed to make an experimental coronavirus vaccine developed by Oxford University researchers as the race ...
Posted by Michael Wonder on 04 May 2020
Boris Johnson’s global vaccine push as he revealed the birth of his son helped him fight COVID-19
4 May 2020 - Boris Johnson will hold a virtual meeting online, and demand countries around the world pull together ...
Posted by Michael Wonder on 23 Apr 2020
The race to find a COVID-19 vaccine
23 April 2020 - The sum of £42.5 million is a lot to pay for a small sliver of protein. ...
Posted by Michael Wonder on 21 Apr 2020
Human trials to begin on COVID-19 vaccine by Thursday
21 April 2020 - A million doses of their experimental coronavirus vaccine could be ready as early as September, Oxford scientists ...
Posted by Michael Wonder on 16 Apr 2020
Meeting highlights from ICMRA global regulatory workshop on COVID-19 observational studies and real world data
16 April 2020 - Observational studies of data generated in clinical practice in the context of COVID-19 can contribute to the ...
Posted by Michael Wonder on 15 Apr 2020
Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19
14 April 2020 - Candidate vaccine expected to enter clinical trials in the second half of 2020 and, if successful, to ...